Serena Telani
University of Genoa
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Serena Telani.
Journal of Ocular Pharmacology and Therapeutics | 2014
Michele Iester; Serena Telani; Paolo Frezzotti; Ilaria Motolese; Michele Figus; Paolo Fogagnolo; Andrea Perdicchi
PURPOSE To determine whether there were ocular surface changes in glaucomatous patients treated with preservatives beta-blockers who switched to preservative-free beta-blockers. METHODS This was a prospective, longitudinal, open-labeled study. One hundred thirty-two patients with primary open angle glaucoma treated with a preserved beta-blocker were enrolled. All the patients underwent perimetric and gonioscopic examination, complete ophthalmologic examination, intraocular pressure (IOP) measurements, evaluation of ocular surface, Schirmers test, blood pressure and heart rate at baseline and 1-3 months after changing the medical treatment to a preservative-free timolol 0.1% (Timogel 0.1; Thea). At baseline, after 1 month and at the end of the study (3 months), all patients underwent a questionnaire on the visual quality and symptoms and on the quality of life (QoL). Data were analyzed by t-test when the distribution of the data was normal, by Mann-Whitney when the distribution was not normal. RESULTS No significant difference was found for IOP before switching from preserved beta-blockers to preservative-free ones. No significant difference was found in blood pressure and heart rate. However, a statistically significant difference was found for abnormal fluorescein staining of the cornea and conjunctiva, eyelid erythema, conjunctival hyperemia, and follicular hyperplasia. A significant difference was found for break-up time (from 9.38±4.7 s at baseline to 10.64±4.7 s after 3 months) and Schirmers test (from 12.9±5.96 mm at baseline to 14.2±5.87 mm after 3 months). The questionnaire showed that the patient improved the dryness and foreign body sensation. CONCLUSION In glaucomatous patients, preservative-free 0.1 timolol treatment improved their QoL. Similar dry eye signs or symptoms improved after 3 months of treatment reducing dryness, hyperemia, follicular hyperplasia, and foreign body sensation.
Journal of Ocular Pharmacology and Therapeutics | 2013
Michele Iester; Serena Telani; Paolo Brusini; Teresa Rolle; Paolo Fogagnolo; Enrico Martini; Giovanni Milano; Daniela Paoli
PURPOSE Supposedly, prostaglandin analogs (PGA) could reduce the central corneal thickness (CCT), while topical carbonic anhydrase inhibitors (TCAI) could increase CCT. The aim of the study was to evaluate clinically significant CCT effects in patients treated with PGA or TCAI. METHODS At least 50 glaucomatous patients were saved on the Italian Glaucoma Register from 16 different glaucoma centers. About 816 glaucomatous patients were found in the register; of these, 316 were recruited in this study because they were treated with PGA or TCAI. The diagnosis of glaucoma was based on visual field examination, optic nerve head analysis, intraocular pressure (IOP) measurements, and gonioscopy. Two age-matched subgroups were created: one treated with PGA and the other with TCAI. CCT, ophthalmoscopic cup/disc ratio (CDR), mean deviation (MD), pattern standard deviation (PSD), and IOP were considered for both eyes of each patient. Student t-test was used to compare the 2 subgroups. RESULTS The mean age of the PGA group was 66.35±12.17 years, while 65.17±12.52 years was for the TCAI group. No significant difference was found for CCT (543.75±35 μm and 544±35 μm, respectively), CDR (0.55±0.2 and 0.53±0.2, respectively), MD (-4.5±4.9 dB and -5.4±6.4 dB, respectively), PSD (4.6±3.4 and 4.6±4.9, respectively), and IOP (15.9±3.3 mmHg and 15.7±2.9 mmHg, respectively) between the 2 subgroups. A significant (P<0.001) correlation was found between CCT and CDR and between CCT and IOP. CONCLUSION No significant difference in CCT was found between patients treated with PGA and TCAI, suggesting that these topical medications did not statistically and clinically change the CCT.
Experimental Eye Research | 2018
Tommaso Rossi; Maria Grazia Badas; Giorgio Querzoli; Carlandrea Trillo; Serena Telani; Laura Landi; Roberto Gattegna; Guido Ripandelli
Abstract Purpose of present study is to evaluate whether the Pre‐Macular Bursa (PMB) modifies Wall Shear Stress (WSS) at the retinal surface during saccadic movements. We created a mathematical model consisting of 25,000 grid cells and simulated a horizontal saccade spanning 50° in 0.17s, both in absence and in presence of the PMB. Wall Shear Stress SS was computed throughout the retinal surface and the posterior pole was divided into 3 Zones comprising 400 nodes each: Zone 1 (radius 3.5 mm; 0°–17°) corresponding to the PMB area; Zone 2 (concentric annular area 5 mm in radius; 22°) and Zone 3 (concentric annular area 5.5 mm; 28°). The PMB reduced WSS significantly at the macula and increased it in the immediate surroundings. Average WSS in Zone 1 was 1.53 ± 1.01 (max 4.23 Pa) with PMB Vs 6.94 ± 9.23 (max 35.83 Pa) without. Zone 2 WSS was 9.39 ± 10.33 (max 48.36 Pa) with PMB Vs 6.95 ± 9.40 (max 38.60 Pa) without Zone 3 WSS was 8.41 ± 10.03 (max 43.16 Pa) with PMB Vs 6.88 ± 9.42 (max 39.43 Pa) without (p < 0.001 in all cases). The PMB significantly reduces WSS over the retinal surface underlying the bursa region; conversely, WSS slightly increases it in the immediate neighboring areas. HighlightsThe Pre‐Macular Bursa (PMB) is a pocket of liquid within the vitreous gel structure and is placed anterior to the macula.The presence of the PMB significantly reduces Wall Shear Stress at the macula during saccadic motion by reducing friction.Shear Stress related gene expression has been largely reported in the literature.Shear stress modifications secondary to PMB disappearance with aging may trigger age‐related disease.
British Journal of Ophthalmology | 2018
Tommaso Rossi; Tomaso Caporossi; Stanislao Rizzo; Carlandrea Trillo; Serena Telani; Francesco Barca; Guido Ripandelli
Purpose To review a series of highly myopic eyes with retinal detachment undergoing pars plana vitrectomy with autologous internal limiting membrane (ILM) flap placed over posterior retinal breaks located in areas of choroidal atrophy. Methods Retrospective review of 13 consecutive patients receiving pars plana vitrectomy with ILM flap over causative breaks, compared with 19 controls receiving the same surgery with ILM peeling but no ILM flap. Main outcome measures included anatomical success rate, visual acuity, number of surgeries and the rate of silicone oil removal. Results Patients in the ILM group required 2.08±0.37 interventions versus 2.58±0.75 in the control group (p=0.037). One (1/13; 7.6%) patient in the ILM group required additional unplanned surgery versus 8/19 (42.10%) in the control group (p=0.038). Final anatomical success rate defined as attached retina after silicone oil (SiO) removal was 13/13 in the I-ILM group and 14/19 (73.6%) in the control group (p=0.052). No patients (0/13) in the I-ILM group retained SiO at the end of follow-up versus 4/19 (21.1%) patients in the control group (p=0.061). Best-corrected visual acuity at the end of follow-up was logMAR 0.65±0.36 (20/91 Snellen) in the ILM group and logMAR 0.89±0.44 (20/158 Snellen) in the control group (p=0.20). Conclusion Autologous ILM may help seal posterior retinal breaks and improve the surgical prognosis of retinal detachment due to breaks located over areas of choroidal atrophy within the myopic staphyloma.
Investigative Ophthalmology & Visual Science | 2017
Chiara Ancona; Paola Cirafici; Serena Telani; Alessandro Masala; Carlo Enrico Traverso; Michele Iester
Investigative Ophthalmology & Visual Science | 2017
Paola Cirafici; Chiara Ancona; Alessandro Masala; Serena Telani; Carlo Enrico Traverso; Michele Iester
Graefes Archive for Clinical and Experimental Ophthalmology | 2017
Tommaso Rossi; Giorgio Querzoli; Aldo Gelso; Giampiero Angelini; Alessandro Rossi; Paolo Corazza; Laura Landi; Serena Telani; Guido Ripandelli
Investigative Ophthalmology & Visual Science | 2016
Laura Landi; Federica Casciaro; Serena Telani; Carlo Enrico Traverso; Michele Iester
OTTICA FISIOPATOLOGICA | 2013
Michele Iester; Paolo Brusini; Paolo Frezzotti; Gianluca Manni; Daniela Paoli; M. Rolando; Teresa Rolle; Maurizio G. Uva; Serena Telani; A. Caprari; R. Altafini; Michele Figus; Enrico Martini; G. Milano; Andrea Perdicchi; Luca Rossetti; Paolo Fogagnolo; Alessandro Rossi; Gemma Caterina Maria Rossi; F. Scrimieri; M. Vetrugno
Investigative Ophthalmology & Visual Science | 2013
Serena Telani; Michele Iester; Paolo Frezzotti; Michele Figus; Paolo Fogagnolo; Andrea Perdicchi; Antonio Ferreras; Carlo Enrico Traverso